curdlan and celecoxib

curdlan has been researched along with celecoxib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cho, ML; Choi, J; Lee, AR; Lee, SY; Min, BM; Min, HK; Park, SH	1

Other Studies

1 other study(ies) available for curdlan and celecoxib

Article	Year
Vitronectin-derived bioactive peptide prevents spondyloarthritis by modulating Th17/Treg imbalance in mice with curdlan-induced spondyloarthritis. PloS one, 2022, Volume: 17, Issue:1 Topics: Animals; beta-Glucans; Celecoxib; Cytokines; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation; Humans; Integrin alphaVbeta3; Integrin beta1; Mice; Peptides; Signal Transduction; Spleen; Spondylarthritis; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Th17 Cells; Vitronectin	2022

Article

Year

Vitronectin-derived bioactive peptide prevents spondyloarthritis by modulating Th17/Treg imbalance in mice with curdlan-induced spondyloarthritis.

PloS one, 2022, Volume: 17, Issue:1

Topics: Animals; beta-Glucans; Celecoxib; Cytokines; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation; Humans; Integrin alphaVbeta3; Integrin beta1; Mice; Peptides; Signal Transduction; Spleen; Spondylarthritis; STAT3 Transcription Factor; T-Lymphocytes, Regulatory; Th17 Cells; Vitronectin

2022